Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo E Vivas-Mejia

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pharmaceuticals (Basel, Switzerland)|November 30, 2013
Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing NanoliposomesMónica Rivera Díaz, Pablo E Vivas-Mejia
Frontiers in Medical Technology|January 20, 2022
Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain BarrierRohit K Sharma, Carlos Calderon, Pablo E Vivas-Mejia
ACS Omega|February 7, 2022
A Fresh Look at the Potential of Cyclodextrins for Improving the Delivery of siRNA Encapsulated in Liposome NanocarriersBetzaida Castillo Cruz, Marienid Flores Colón, Robert J Rabelo Fernandez, et al.
International Journal of Molecular Sciences|December 11, 2022
Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer CellsRobert J Rabelo-Fernández, Ricardo A Noriega Rivera, Yasmarie Santana Rivera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2011
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancerPablo E Vivas-Mejia, Cristian Rodriguez-Aguayo, Hee-Dong Han, et al.
Biomolecules|November 27, 2025
Molecular Basis of Simalikalactone D Sensitivity in Triple-Negative Breast Cancer CellsAnnelis O Sánchez-Álvarez, Joshua Nieves-Reyes, Gabriel Borges-Vélez, et al.
Frontiers in Oncology|September 27, 2023
MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastomaNilmary Grafals-Ruiz, Annelis O Sánchez-Álvarez, Yasmarie Santana-Rivera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cellsXue Pan, Thiruvengadam Arumugam, Tameyoshi Yamamoto, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Effect of Cyclodextrins Formulated in Liposomes and Gold and Selenium Nanoparticles on siRNA Stability in Cell Culture MediumBetzaida Castillo Cruz, Sandra Chinapen Barletta, Bryan G Ortiz Muñoz, et al.
Cancer Research|November 1, 2008
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNAGabriel J Villares, Maya Zigler, Hua Wang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|November 30, 2013
Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing NanoliposomesMónica Rivera Díaz, Pablo E Vivas-Mejia
Frontiers in Medical Technology|January 20, 2022
Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain BarrierRohit K Sharma, Carlos Calderon, Pablo E Vivas-Mejia
ACS Omega|February 7, 2022
A Fresh Look at the Potential of Cyclodextrins for Improving the Delivery of siRNA Encapsulated in Liposome NanocarriersBetzaida Castillo Cruz, Marienid Flores Colón, Robert J Rabelo Fernandez, et al.
International Journal of Molecular Sciences|December 11, 2022
Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer CellsRobert J Rabelo-Fernández, Ricardo A Noriega Rivera, Yasmarie Santana Rivera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2011
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancerPablo E Vivas-Mejia, Cristian Rodriguez-Aguayo, Hee-Dong Han, et al.
Biomolecules|November 27, 2025
Molecular Basis of Simalikalactone D Sensitivity in Triple-Negative Breast Cancer CellsAnnelis O Sánchez-Álvarez, Joshua Nieves-Reyes, Gabriel Borges-Vélez, et al.
Frontiers in Oncology|September 27, 2023
MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastomaNilmary Grafals-Ruiz, Annelis O Sánchez-Álvarez, Yasmarie Santana-Rivera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cellsXue Pan, Thiruvengadam Arumugam, Tameyoshi Yamamoto, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Effect of Cyclodextrins Formulated in Liposomes and Gold and Selenium Nanoparticles on siRNA Stability in Cell Culture MediumBetzaida Castillo Cruz, Sandra Chinapen Barletta, Bryan G Ortiz Muñoz, et al.
Cancer Research|November 1, 2008
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNAGabriel J Villares, Maya Zigler, Hua Wang, et al.
Pageof 2